Degenerative Myelopathy in Dogs: Managing a Progressive Disease

Canine degenerative myelopathy is a progressive neurodegenerative disease affecting the spinal cord. Understanding the disease progression and welfare management options helps owners provide the best quality of life for affected dogs.

Key Facts

Degenerative myelopathy most commonly affects German Shepherds, Welsh Corgis, Boxers, and Chesapeake Bay Retrievers
A mutation in the SOD1 gene is associated with the disease in most affected breeds
The disease typically begins with hindlimb weakness and ataxia progressing to complete paralysis over 6 to 18 months
There is currently no cure or treatment proven to halt progression
Regular physiotherapy and hydrotherapy can slow functional decline and maintain quality of life
Wheelchairs and mobility aids allow dogs to remain mobile and engaged in the intermediate stages
Genetic testing can identify dogs at higher risk before they show clinical signs

Welfare Considerations

Dogs with degenerative myelopathy gradually lose the ability to walk, control bladder and bowel function, and eventually breathe independently. Welfare management requires anticipating each stage and adapting support accordingly. Physiotherapy slows decline and maintains muscle mass. Mobility aids preserve independence and mental engagement. Careful monitoring of quality-of-life indicators helps owners and veterinarians make timely decisions about euthanasia before suffering becomes severe.

What You Can Do

If your breed is at risk, consider genetic testing for the SOD1 mutation before breeding
Seek a veterinary physiotherapist experienced in degenerative myelopathy management
Consider a canine wheelchair early — dogs adapt better when introduced before severe weakness
Use validated quality-of-life assessment tools to guide end-of-life decisions
Connect with support groups for owners managing dogs with degenerative myelopathy